*Some Market data delayed by 15 mins.

Sensus Healthcare, Inc

Symbol: SRTS (NASDAQ)
3.24 ▲ (1.38%) 0.044

Company Description:
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Key Stats
  • Today's Open: $3.19
  • Today's High: $3.25
  • Today's Low: $3.192
  • Today's Volume: 13.11K
  • Yesterday Close: $3.2
  • Yesterday High: $3.28
  • Yesterday Low: $3.16
  • Yesterday Volume: 95.32K
  • Last Min Volume: 0
  • Last Min High: $3.244
  • Last Min Low: $3.228
  • Last Min VWAP: $0
Company Profile
  • Name: Sensus Healthcare, Inc
  • Website: https://www.sensushealthcare.com
  • Listed Date: 2016-07-25
  • Location: BOCA RATON, FL
  • Market Status: Active
  • CIK Number: 0001494891
  • SIC Code: 3841
  • SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • Market Cap: $52.61M
  • Round Lot: 100
  • Outstanding Shares: 16.44M
  • Asset Type: CS
RECENT FILINGS FOR SRTS
Filing Date Filing Type Format
2025-08-15 S-8 View
2025-08-14 4 View
2025-08-12 10-Q View
2025-08-07 8-K View
2025-06-10 3 View
2025-06-02 8-K View
2025-05-30 SD View
2025-05-22 SCHEDULE 13G/A View
2025-05-15 10-Q View
2025-05-15 8-K View
2025-04-29 DEF 14A View
2025-03-05 10-K View
2025-02-11 8-K View
2025-02-10 4 View
2025-02-10 4 View
2025-02-07 SCHEDULE 13G/A View
2025-02-05 8-K View
2024-12-19 4 View
2024-12-19 4 View
2024-12-19 4 View
Latest News on SRTS

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.